Loading clinical trials...
Loading clinical trials...
A Randomized, Observer-Blinded, Within Patient Bilateral Comparison to Study the Safety and Efficacy of Daily Application for 4 Weeks of DBI-001 Gel Versus Aqueous Gel in Subjects With Atopic Dermatitis
Conditions
Interventions
DBI-001
Aqueous gel
Locations
3
United States
Investigate MD, LLC
Scottsdale, Arizona, United States
DermResearch, Inc.
Austin, Texas, United States
North Sound Dermatology
Mill Creek, Washington, United States
Start Date
October 6, 2021
Primary Completion Date
September 9, 2022
Completion Date
September 9, 2022
Last Updated
November 8, 2023
NCT07262983
NCT06389136
NCT06342713
NCT07290803
NCT07223697
NCT07265479
Lead Sponsor
DermBiont, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions